The present invention is directed to inhibitors of TGF-.beta. of Formula I: ##STR00001##

 
Web www.patentalert.com

< Intraocular lenses with fixated haptics

> Cationic hydrophilic siloxanyl monomers

> Contact lens
~ 00508